Lista de obras -

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer

artículo científico publicado en 2005

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

artículo científico publicado en 2020

Akt activation correlates with adverse outcome in tongue cancer

article

An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites

artículo científico publicado en 2020

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma

artículo científico publicado en 2012

Checkpoint inhibitors in lung cancer: latest developments and clinical potential

artículo científico publicado en 2016

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.

artículo científico publicado en 2018

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial

article

Comparing outcomes of concurrent chemotherapy regimens in patients 65 years or older with locally advanced oropharyngeal carcinoma

artículo científico publicado en 2018

Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy

scientific article published on 21 December 2021

Early mortality of stage IV non-small cell lung cancer in the United States

artículo científico publicado en 2019

Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas

artículo científico publicado en 2008

FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials

artículo científico publicado en 2020

Factors predicting for patient refusal of head and neck cancer therapy

artículo científico publicado en 2019

High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer

scientific article published on 16 December 2019

High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor

artículo científico publicado en 2005

Human Lung Fibroblasts Inhibit Non-Small Cell Lung Cancer Metastasis in Ex Vivo 4D Model

artículo científico publicado en 2015

Immune Checkpoint Therapy in Head and Neck Cancers

artículo científico publicado en 2016

Immunotherapy in lung cancer

artículo científico publicado en 2014

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial

artículo científico publicado en 2009

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

artículo científico publicado en 2016

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

artículo científico

Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis

scientific article published on 01 March 2005

Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?

scientific article published on 18 September 2020

New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic

artículo científico

New targets for the treatment of advanced non-small cell lung cancer

artículo científico publicado el 1 de enero de 2002

Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio

scientific article published on 19 May 2019

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

artículo científico publicado en 2017

Perspectives in Head and Neck Medical Oncology

artículo científico publicado en 2018

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses

scientific article published on 28 October 2019

Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 1 de diciembre de 2012

Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma

artículo científico publicado en 2019

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly

artículo científico publicado en 2004

Precision medicine and actionable alterations in lung cancer: A single institution experience

scientific article published on 11 February 2020

Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

artículo científico publicado en 2018

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

artículo científico publicado en 2019

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer

artículo científico publicado en 2004

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres

artículo científico publicado en 2004

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance ⬇️

artículo científico publicado el 26 de febrero de 2013

Use of novel second-line targeted therapies in non-small cell lung cancer

artículo científico publicado en 2006

Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion

artículo científico publicado en 2014

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer

Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure

Akt activation correlates with adverse outcome in tongue cancer

An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma

Checkpoint inhibitors in lung cancer: latest developments and clinical potential

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial

Comparing outcomes of concurrent chemotherapy regimens in patients 65 years or older with locally advanced oropharyngeal carcinoma

Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy

Early mortality of stage IV non-small cell lung cancer in the United States

Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinomas

FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials

Factors predicting for patient refusal of head and neck cancer therapy

High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer

High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor

Human Lung Fibroblasts Inhibit Non-Small Cell Lung Cancer Metastasis in Ex Vivo 4D Model

Immune Checkpoint Therapy in Head and Neck Cancers

Immunotherapy in lung cancer

Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesis

Nasopharyngeal Cancer: Is the Addition of Chemotherapy to Radiotherapy Worthwhile in an Era of Value-Based Care?

New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic

New targets for the treatment of advanced non-small cell lung cancer

Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio

Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.

Perspectives in Head and Neck Medical Oncology

Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses

Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in Non–Small-Cell Lung Cancer ⬇️

Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma

Potential role of molecularly targeted therapy in the management of advanced nonsmall cell lung carcinoma in the elderly

Precision medicine and actionable alterations in lung cancer: A single institution experience

Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.

Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer

Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistance ⬇️

Use of novel second-line targeted therapies in non-small cell lung cancer

Vandetanib and indwelling pleural catheter for non-small-cell lung cancer with recurrent malignant pleural effusion